Canntab Therapeutics and Heritage Cannabis strike deal to work together

Canntab Therapeutics and Heritage Cannabis strike deal to work together

Heritage Cannabis (CSE:CANN) President and CEO Clint Sharples and Canntab Therapeutics (CSE:PILL) CFO Richard Goldstein joined Christine Corrado from Proactive Investors New York to talk about their partnership that seems to really benefit both companies.

Heritage’s subsidiary Purefarma Solutions will provide
processing services for hemp supplied by Canntab, to their specification, as required for the production of Canntab’s planned ingestible oral cannabis products.